Search

The urea oxidation reaction (UOR), requiring less energy to produce hydrogen, is considered as a potential alternative to the traditional oxygen evolution reaction. Consequently, developing highly efficient UOR catalysts to facilitate H2 production has garnered widespread attention. A promising approach to enhancing the effectiveness of these electrocatalysts is defect engineering. By introducing structural defects, defect engineering can expose more active sites and optimize their electronic structure, thereby improving their activity. This work offers a comprehensive overview of recent progress in defect engineering of nickel-based electrocatalysts for the UOR. It summarizes various strategies for generating defects, including the creation of vacancies, doping, the incorporation of single atoms, amorphization, and achieving high refractivity. Furthermore, we discuss the advanced characterization techniques commonly used to identify the presence of defects in these electrocatalysts, as well as to determine their detailed structures. Finally, we outline the prospects and challenges associated with the systematic design and fabrication of novel UOR electrocatalysts with tunable defects, aiming to further enhance their efficiency and stability.

Fluorescent nanoparticles (NPs) have been increasingly studied as contrast agents for better understanding of biological processes at the cellular and molecular level. However, their use as bioimaging tools is strongly dependent on their optical emission as well as their biocompatibility. This work reports the fabrication and characterization of silk fibroin (SF) coated magnesium oxide (MgO) nanospheres, containing oxygen, Cr3+ and V2+ related optical defects, as a nontoxic and biodegradable hybrid platform for bioimaging applications. The MgO-SF spheres demonstrated enhanced emission efficiency compared to noncoated MgO NPs. Furthermore, SF sphere coating was found to overcome agglomeration limitations of the MgO NPs. The hybrid nanospheres were investigated as an in vitro bioimaging tool by recording their cellular uptake, trajectories, and mobility in human skin keratinocytes cells (HaCaT), human glioma cells (U87MG) and breast cancer cells (MCF7). Enhanced cellular uptake and improved intracellular mobilities of MgO-SF spheres compared to MgO NPs was demonstrated in three different cell lines. Validated infrared and bright emission of MgO-SF NP indicate their prospects for in vivo imaging. The results identify the potential of the hybrid MgO-SF nanospheres for bioimaging. This study may also open new avenues to optimize drug delivery through biodegradable silk and provide noninvasive functional imaging feedback on the therapeutic processes through fluorescent MgO.